BioSpace News Archive

Asimov announced today that it will deliver an oral presentation at the 26th annual meeting of the American Society of Gene and Cell Therapy (ASGCT) being held as an in-person meeting on May 16–20, 2023 at the Los Angeles Convention Center.

ZyVersa Therapeutics, Inc. announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, will participate in A.G.P.’s Virtual Healthcare Conference being held May 23 - 24, 2023.

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) today announced that the company and its collaborators will present a broad range of clinical and translational data at the European Hematology Association (EHA) Hybrid Congress, hosted virtually and in person in Frankfurt, Germany, June 8-11, 2023, and continuing virtually on the Congress platform June 14-15, 2023.

Polarean Imaging plc, the medical imaging company, announces that the first clinical scan utilising its XENOVIEW technology in the United States has taken place at Cincinnati Children’s Hospital Medical Center.

Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that data from its oncology portfolio will be presented at the 2023 European Hematology Association (EHA) Annual Meeting, to be held June 8 – 11, 2023, in Frankfurt, Germany, and virtually.

Poolbeg Pharma, a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, announces that at the Annual General Meeting held at 12:00pm , all resolutions were duly passed.

The American Urological Association announced that Logan Galansky, MD, has been named the 2023-2024 H. Logan Holtgrewe Legislative Fellow.

Following the April 22 announcement of the world’s first positive clinical trial for hemorrhagic stroke, trial sponsor NICO Corporation announced that it is infusing another $1 million into its Investigator Initiated Study Grant Program to support further scientific advancements in vascular, tumor, and oncology precision medicine using its novel neurosurgical technologies.

Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has announced the publication of four PCT patent applications covering novel improvements to the empathogens methylone (also known as bk-MDMA or MDMC), ethylone, MDEA (also known as MDE), MDAI, and MBDB.

Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business updates and financial results for the first quarter ended March 31, 2023.